Quo vadis, biological treatment for psoriasis and psoriatic arthritis?

Postȩpy dermatologii i alergologii
Barbara OlszewskaMagdalena Czarnecka-Operacz

Abstract

Psoriasis is a chronic autoimmune disease that affects approximately 2-3% of the world's population. Although the cutaneous manifestations of the disease are the most prevalent, psoriasis is also associated with a systemic inflammation and various co-morbidities linked with autoinflammatory processes. One of those processes is psoriatic arthritis, an inflammatory, seronegative spondyloarthropathy that develops in 13.8-30% of psoriatic patients at some point of their lives. Over the past 15 years the therapeutic options for severe and generalized psoriasis have broadened immensely with the introduction of biological agents to everyday practice. We present a quick overview of current biological therapies in the treatment of psoriasis and prospects for forthcoming advancements in biological treatment.

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Acta Medica Croatica : C̆asopis Hravatske Akademije Medicinskih Znanosti
Zrinka Jajić, Gazi el Assadi
The Journal of Rheumatology
Raffaele ScarpaIgnazio Olivieri
Dermatologic Therapy
Mercedes Gómez Vázquez, Ramón Navarra Amayuelas
Clinical and Experimental Rheumatology
A S Russell, M E Suarez-Almazor
© 2022 Meta ULC. All rights reserved